Rhumbline Advisers Harvard Bioscience Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Rhumbline Advisers holds 38,727 shares of HBIO stock, worth $82,875. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,727
Previous 47,753 18.9%
Holding current value
$82,875
Previous $136,000 23.53%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$2.64 - $3.54 $23,828 - $31,952
-9,026 Reduced 18.9%
38,727 $104,000
Q2 2024

Aug 01, 2024
BUY
$2.77 - $4.63 $26,348 - $44,040
9,512 Added 24.87%
47,753 $136,000
Q1 2024

May 09, 2024
BUY
$4.02 - $5.39 $6,677 - $8,952
1,661 Added 4.54%
38,241 $162,000
Q4 2023

Feb 08, 2024
SELL
$4.0 - $5.49 $468 - $642
-117 Reduced 0.32%
36,580 $195,000
Q3 2023

Nov 09, 2023
BUY
$4.0 - $5.82 $8,564 - $12,460
2,141 Added 6.2%
36,697 $157,000
Q2 2023

Aug 08, 2023
BUY
$4.19 - $6.16 $144,789 - $212,864
34,556 New
34,556 $189,000
Q2 2022

Aug 11, 2022
SELL
$3.28 - $6.42 $118,703 - $232,339
-36,190 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$5.16 - $7.14 $59,432 - $82,238
11,518 Added 46.68%
36,190 $225,000
Q4 2021

Feb 10, 2022
SELL
$6.37 - $8.18 $4,044 - $5,194
-635 Reduced 2.51%
24,672 $174,000
Q3 2021

Nov 12, 2021
BUY
$6.98 - $8.47 $12,564 - $15,246
1,800 Added 7.66%
25,307 $177,000
Q2 2021

Aug 05, 2021
SELL
$5.44 - $8.4 $106,009 - $163,690
-19,487 Reduced 45.32%
23,507 $196,000
Q1 2021

May 06, 2021
SELL
$3.91 - $6.99 $5,239 - $9,366
-1,340 Reduced 3.02%
42,994 $235,000
Q4 2020

Feb 10, 2021
BUY
$3.0 - $4.5 $24,198 - $36,297
8,066 Added 22.24%
44,334 $190,000
Q3 2020

Nov 12, 2020
SELL
$2.75 - $4.2 $22,151 - $33,831
-8,055 Reduced 18.17%
36,268 $109,000
Q2 2020

Aug 13, 2020
BUY
$2.12 - $3.14 $93,964 - $139,174
44,323 New
44,323 $137,000
Q2 2019

Aug 14, 2019
SELL
$1.93 - $4.59 $93,880 - $223,271
-48,643 Closed
0 $0
Q1 2019

May 01, 2019
SELL
$2.77 - $4.38 $734 - $1,160
-265 Reduced 0.54%
48,643 $210,000
Q4 2018

Jan 31, 2019
BUY
$3.03 - $5.0 $47,992 - $79,195
15,839 Added 47.9%
48,908 $156,000
Q3 2018

Nov 07, 2018
BUY
$5.0 - $6.65 $11,920 - $15,853
2,384 Added 7.77%
33,069 $174,000
Q2 2018

Aug 06, 2018
BUY
$4.2 - $5.95 $128,877 - $182,575
30,685 New
30,685 $164,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email